AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AnGes Inc (4563) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10137
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two projects under development, namely, a hepatocyte growth factor (HGF) plasmid, a genetic medicine that regenerates blood vessels improving blood circulation and NF-KB decoy oligonuvleotide. It also develops therapeutic vaccine projects including, Allovectin, a cancer treatment drug; and DNA and CIN (cervical intraepithelial neoplasia) therapeutic vaccines. AnGes is headquartered in Osaka, Japan.

AnGes Inc (4563) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AnGes Inc, Medical Devices Deals, 2012 to YTD 2018 9
AnGes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AnGes Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Vasomune and AnGes Enter into Co-Development Agreement 11
Vical Enters into Co-Development Agreement with AnGes 12
AnGes MG Enters into Agreement with VIDO-InterVac 13
Vical Enters into Agreement with AnGes to Develop and Commercialize Equine Polyclonal Antibody Therapy 14
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 15
AnGes MG Enters Into Co-Marketing Agreement With Mitsubishi Tanabe Pharma For Collategene 16
AnGes MG Enters into Agreement with Morishita Jintan 17
AnGes Enters Into Co-Development Agreement With BioLeaders For Hypertension Vaccine 18
Licensing Agreements 19
AnGes MG Enters into Licensing Agreement with Morishita Jintan 19
AnGes Enters into Licensing Agreement with Mitsubishi Tanabe Pharma 20
AnGes Exercises Option for Licensing Agreement with BioLeaders and GenoLac 21
Equity Offering 22
Vical Raises up to USD7.8 Million in Private Placement of Shares 22
AnGes MG Raises USD2.6 Million in Private Placement of Shares upon Exercise of Warrants 23
AnGes Announces Private Placement Of Shares For US$52 Million 24
AnGes Announces Private Placement Of Shares For US$2.5 Million 25
AnGes Inc – Key Competitors 26
AnGes Inc – Key Employees 27
AnGes Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Product Approvals 29
Mar 24, 2017: AnGes: Investigational New Drug (IND) Application Submitted to the FDA 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
AnGes Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AnGes Inc, Medical Devices Deals, 2012 to YTD 2018 9
AnGes Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vasomune and AnGes Enter into Co-Development Agreement 11
Vical Enters into Co-Development Agreement with AnGes 12
AnGes MG Enters into Agreement with VIDO-InterVac 13
Vical Enters into Agreement with AnGes to Develop and Commercialize Equine Polyclonal Antibody Therapy 14
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 15
AnGes MG Enters Into Co-Marketing Agreement With Mitsubishi Tanabe Pharma For Collategene 16
AnGes MG Enters into Agreement with Morishita Jintan 17
AnGes Enters Into Co-Development Agreement With BioLeaders For Hypertension Vaccine 18
AnGes MG Enters into Licensing Agreement with Morishita Jintan 19
AnGes Enters into Licensing Agreement with Mitsubishi Tanabe Pharma 20
AnGes Exercises Option for Licensing Agreement with BioLeaders and GenoLac 21
Vical Raises up to USD7.8 Million in Private Placement of Shares 22
AnGes MG Raises USD2.6 Million in Private Placement of Shares upon Exercise of Warrants 23
AnGes Announces Private Placement Of Shares For US$52 Million 24
AnGes Announces Private Placement Of Shares For US$2.5 Million 25
AnGes Inc, Key Competitors 26
AnGes Inc, Key Employees 27
AnGes Inc, Other Locations 28
AnGes Inc, Subsidiaries 28

List of Figures
AnGes Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnGes Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnGes Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AnGes Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Red Sky Energy Limited (ROG):企業概要、財務及び戦略的SWOT分析
    Summary Red Sky Energy (Red Sky) is an oil and gas exploration company. The company explores oil and coal steam gas. Its gas exploration projects include the Clarence Moreton project, which has gas reserve position in Walloon coals in the Clarence Moreton Basin in north east New South Wales. The com …
  • Indigo Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, mitochondrial function products, and luciferase detection reagents. …
  • Ansaldo Energia SpA-エネルギー分野:企業M&A・提携分析
    Summary Ansaldo Energia S.p.A. (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipments and related services. It provides power plant equipments such as gas turbines, steam turbines, turbogenerators, and hydrogenerators used in fossil …
  • OceanFirst Financial Corp., Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OceanFirst Financial Corp., Inc …
  • United Parcel Service Inc (UPS):企業の財務・戦略的SWOT分析
    United Parcel Service Inc (UPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Applied Industrial Technologies Inc (AIT):石油・ガス:M&Aディール及び事業提携情報
    Summary Applied Industrial Technologies Inc. (Applied Industrial) is a distributor of industrial products and services to MRO and OEM customers. The company also provides engineering, design and systems integration services for industrial and fluid power applications, besides tailored mechanical, fa …
  • Affiliated Computer Services, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Affiliated Computer Services, I …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • SunLink Corporation:企業のM&A・提携動向(発電分野)
    Summary SunLink Corporation (SunLink) is an energy company that designs, manufactures and markets integrated solar PV system solutions. The company offers products such as roof mount systems, ground mount systems, combiner boxes and others. It undertakes and operates commercial and utility-scale sol …
  • Oasis Petroleum Inc (OAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Oasis Petroleum Inc. (Oasis Petroleum) is an independent exploration and production company. It focuses on the acquisition and development of unconventional oil and natural gas resources. The company operates in the Williston Basin in North Dakota and Montana and Permian Basin. The company f …
  • Evros Technology Group:企業の戦略・SWOT・財務分析
    SummaryEvros Technology Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Cytori Therapeutics, Inc.:企業のM&A・提携・投資分析
    Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cytori Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Fimalac (FIM):企業の財務及び戦略的SWOT分析
    Summary Fimalac is a financial consulting company that provides investment services. The company offers services such as financial services, fimalac development, digital advising and real estate services. Its financial services include structured finance, public finance, and global infrastructure an …
  • Jurong Technologies Industrial Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Jurong Technologies Industrial …
  • GW Pharmaceuticals Plc (GWP):企業のM&A・提携動向(医療機器分野)
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s product Sativex is a plant-derived cannabinoid prescription drug, for the treatment …
  • Unit Corporation (UNT):企業のM&A・提携動向(石油・ガス分野)
    Summary Unit Corporation (Unit) is an oil and gas company that offers contract drilling, oil and natural gas, and mid-stream operations. The company’s contract drilling segment contracts to drill onshore oil and natural gas wells for others. Its oil and natural gas segment explores, develops, purcha …
  • Luna Innovations Incorporated (LUNA):企業概要、財務及び戦略的SWOT分析
    Summary Luna Innovations Incorporated (Luna) research, develops and commercializes products, such as fiber optic testing solutions and fiber sensing solutions. Luna’s fiber optic testing solutions include component analyzers, reflectometers, tunable lasers, optical switches, optical backscatter refl …
  • Altima Resources Ltd. (ARH):企業の財務及び戦略的SWOT分析
    Summary Altima Resources Ltd. (Altima) is a mineral exploration company that provides exploration and development of petroleum and natural gas. The company operates exploration programs in moderate depth, multi-zone prospects that are near known pools and geologically tested areas. It offers explora …
  • Mirach Energy Limited (C68):企業概要、財務及び戦略的SWOT分析
    Summary Mirach energy limited (Mirach), formerly known as China Petrotech Holdings Limited, is an energy exploration and Production company. It explores and produces oil and gas with interests in Asia. Mirach operates through Oilfield Services, Oil Exploration and Oilfield Development segments. It o …
  • CYTOO SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CYTOO SA Mergers and Acquisitio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆